Differential effects of isoflurane and i.v. anaesthetic agents on metabolism of alveolar type II cells

British Journal of Anaesthesia

Volumn 82, Issue 5, 1999, Pages 767-769

  Molliex, S ^a,b   Crestani, B ^b   Dureuil, B ^b,c   Rolland, C ^b   Aubier, M ^b   Desmonts, J M ^b,c  

^a SERVICE DE NEUROLOGIE   (France)

^b INSERM   (France)

^c BICHAT HOSPITAL   (France)

Author keywords

Anaesthetics i.v; Anaesthetics volatile, isoflurane; Lung, alveolus; Lung, metabolic function; Lung, surfactant

Indexed keywords

INHALATION ANESTHETIC AGENT; ISOFLURANE; LACTATE DEHYDROGENASE; PHOSPHATIDYLCHOLINE;

ANIMAL CELL; ARTICLE; CELL METABOLISM; GLYCOLYSIS; LUNG ALVEOLUS CELL TYPE 2; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0032924030     PISSN: 00070912     EISSN: None     Source Type: Journal    
DOI: 10.1093/bja/82.5.767     Document Type: Article

References (6)

1. Dobbs LG. Isolation and culture of alveolar type II cells. Am J Physiol 1990; 258: L134-47
2. Van Golde LMG, Batenburg JJ, Robertson B. The pulmonary surfactant system: biochemical aspects and functional significance. Physiol Rev 1988; 68: 374-455
3. Molliex S, Crestani B, Dureuil B, et al. Effects of halothane on surfactant biosynthesis by rat alveolar type II cells in primary culture. Anesthesiology 1994; 81: 668-76
4. Elliott RH, Strunin L. Hepatotoxicity of volatile anaesthetics. Br J Anaesth 1993; 70: 339-48
5. Hall GM, Kirtland SJ, Baum H. The inhibition of mitochondrial respiration by inhalational anaesthetic agents. Br J Anaesth 1973; 45: 1005-9
6. Wright JR, Clements JA. Metabolism and turnover of lung surfactant Am Rev Respir Dis 1987; 135: 426-44